Literature DB >> 18355203

Expression of human beta-defensin-2 and -3 in verrucae vulgares and condylomata acuminata.

U Meyer-Hoffert1, T Schwarz, J-M Schröder, R Gläser.   

Abstract

The human beta defensins (hBDs) 2 and 3 contribute to the inducible antimicrobial peptides in human skin. Besides an important role in fighting bacteria, they may also exert antiviral function. Verrucae vulgares and condylomata acuminata are typical cutaneous viral diseases caused by different subtypes of the human papillomavirus. Their tendency for spontaneous regression could be caused by antiviral proteins like defensins. In a retoperspective study, we investigated lesions of verrucae vulgares and condylomata acuminata for the presence of hBD-2 and hBD-3 by immunohistochemistry. All of the specimens of verrucae vulgares (n = 20) were positive for hBD-2 and hBD-3. The specimens of condylomata acuminata (n = 15) exhibited expression for hBD-2 and hBD-3, with the exception of three and two samples, respectively. The expression levels in condyloma acuminata were lower for both defensins compared with verrucae vulgares. Normal skin tissue exhibited no staining of both hBD-2 and hBD-3 with the exception of two cases. Taken together, this is the first report of an increased expression of the hBD-2 and hBD-3 in cutaneous papillomavirus infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355203     DOI: 10.1111/j.1468-3083.2008.02675.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  6 in total

1.  Activity, expression and genetic variation of canine β-defensin 103: a multifunctional antimicrobial peptide in the skin of domestic dogs.

Authors:  Brian C Leonard; Stanley L Marks; Catherine A Outerbridge; Verena K Affolter; Anchasa Kananurak; Amy Young; Peter F Moore; Danika L Bannasch; Charles L Bevins
Journal:  J Innate Immun       Date:  2012-01-19       Impact factor: 7.349

2.  [The skin's own antibiotics. Important features of antimicrobial peptides for clinical practice].

Authors:  J Cordes; M Wittersheim; J Harder; R Gläser
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

3.  Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi's sarcoma.

Authors:  Hanan Fathy; Maha M Amin; Abdel-Hady El-Gilany
Journal:  F1000Res       Date:  2012-10-26

Review 4.  The role of antimicrobial peptides in chronic inflammatory skin diseases.

Authors:  Małgorzata Marcinkiewicz; Sławomir Majewski
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

Review 5.  Antiviral peptides as promising therapeutic drugs.

Authors:  Liana Costa Pereira Vilas Boas; Marcelo Lattarulo Campos; Rhayfa Lorrayne Araujo Berlanda; Natan de Carvalho Neves; Octávio Luiz Franco
Journal:  Cell Mol Life Sci       Date:  2019-05-17       Impact factor: 9.261

Review 6.  Potential "biopeptidal" therapeutics for severe respiratory syndrome coronaviruses: a review of antiviral peptides, viral mechanisms, and prospective needs.

Authors:  Tolulope Joshua Ashaolu; Asad Nawaz; Noman Walayat; Ibrahim Khalifa
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-19       Impact factor: 4.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.